Skip to main content
Premium Trial:

Request an Annual Quote

What Does it Mean?: Feb 4, 2013

A $125,000 machine from Knome aims to take the pain out of genome analysis. As The New York Times reports, the cost of sequencing a human genome is dropping, though analysis is still an issue and the machine, called the knoSYSTM100, may help researchers interpret what those sequences mean. For an extra $25,000 a year, users can get software updates and technical support.

"Basically this machine removes the need to maintain an expensive computational facility and a group of people who make sure the operating system is working and keep the reference data up to date," Peter Nagy from Columbia University says. He tells the Times that he is thinking about getting the machine to use in the clinic.

The machine, the Times adds, could be a boon for smaller labs that don't have access to such computational resources.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.